emtricitabine has been researched along with Sexually Transmitted Disease, Viral in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, PL; De Boni, RB; Freitas, L; Goulart, S; Grinsztejn, B; Hoagland, B; Kallas, EG; Leite, IC; Liu, A; Luz, PM; Madruga, JV; Martins, LMS; Moreira, RI; Torres, TS; Vasconcelos, R; Veloso, VG | 1 |
| Bradshaw, CS; Chen, MY; Chow, EPF; Cornelisse, VJ; Fairley, CK; Fortune, R; Needleman, R; Towns, JM; Yang, TZT | 1 |
| Eichner, A; Shalit, P; Thomas, A; Tung, EL | 1 |
1 trial(s) available for emtricitabine and Sexually Transmitted Disease, Viral
| Article | Year |
|---|---|
Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
Topics: Administration, Oral; Adult; Brazil; Emtricitabine; Feasibility Studies; Female; HIV Infections; Homosexuality, Male; Humans; Incidence; Male; Medication Adherence; Middle Aged; Pre-Exposure Prophylaxis; Risk-Taking; Sexually Transmitted Diseases, Viral; Tenofovir; Transgender Persons; Young Adult | 2018 |
2 other study(ies) available for emtricitabine and Sexually Transmitted Disease, Viral
| Article | Year |
|---|---|
Access to sexual health services after the rapid roll out of the launch of pre-exposure prophylaxis for HIV in Melbourne, Australia: a retrospective cross-sectional analysis.
Topics: Adolescent; Adult; Anti-HIV Agents; Cross-Sectional Studies; Drug Therapy, Combination; Emtricitabine; Female; Health Services Accessibility; Health Services Needs and Demand; HIV Infections; Humans; Male; Middle Aged; Pre-Exposure Prophylaxis; Retrospective Studies; Sexually Transmitted Diseases, Viral; Tenofovir; Victoria | 2018 |
Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-HIV Agents; Community Pharmacy Services; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; Humans; Male; Middle Aged; Pre-Exposure Prophylaxis; Sexually Transmitted Diseases, Viral; Tenofovir; Washington | 2018 |